Synopsis
Synopsis
0
VMF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dihydrohydroxycodeinone
2. Dihydrone
3. Dinarkon
4. Eucodal
5. Oxiconum
6. Oxycodeinon
7. Oxycodone
8. Oxycone
9. Oxycontin
10. Pancodine
11. Theocodin
1. 124-90-3
2. Oxycodone Hcl
3. Oxecta
4. Oxycontin
5. Endocodone
6. Roxicodone
7. Oxycodone Hydrochloride Cii
8. Chebi:7859
9. 4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride
10. (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride
11. (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydron;chloride
12. Roxicodone (tn)
13. Oxycontin (tn)
14. (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
15. Oxecta (tn)
16. Roxybond
17. Oxycodone Monohydrochloride
18. Schembl30095
19. Oxycodone Hydrochloride (usp)
20. Chembl1200890
21. Dtxsid80924674
22. Oxycodone Hydrochloride [mi]
23. Oxycodone Hydrochloride [usan]
24. Akos024457896
25. Oxycodone Hydrochloride [mart.]
26. Oxycodone Hydrochloride [vandf]
27. Anhydrous Oxycodone Hydrochloride
28. Oxycodone Hydrochloride [who-dd]
29. Oxycodone Hydrochloride, Analytical Standard
30. Oxycodone Hydrochloride [orange Book]
31. Oxycodone Hydrochloride Cii [usp-rs]
32. Oxycodone Hydrochloride [ep Monograph]
33. Tylox Component Oxycodone Hydrochloride
34. C08026
35. Codoxy Component Oxycodone Hydrochloride
36. D00847
37. Oxycet Component Oxycodone Hydrochloride
38. Oxycodone Hydrochloride [usp Monograph]
39. Roxicet Component Oxycodone Hydrochloride
40. Roxilox Component Oxycodone Hydrochloride
41. Troxyca Component Oxycodone Hydrochloride
42. Combunox Component Oxycodone Hydrochloride
43. Oxycodone Hydrochloride Component Of Tylox
44. Percocet Component Oxycodone Hydrochloride
45. Percodan Component Oxycodone Hydrochloride
46. Roxiprin Component Oxycodone Hydrochloride
47. Targiniq Component Oxycodone Hydrochloride
48. Xartemis Component Oxycodone Hydrochloride
49. Oxycodone Hydrochloride Component Of Codoxy
50. Oxycodone Hydrochloride Component Of Oxycet
51. Oxycodone Hydrochloride Component Of Roxicet
52. Oxycodone Hydrochloride Component Of Roxilox
53. Oxycodone Hydrochloride Component Of Troxyca
54. Oxycodone Hydrochloride Component Of Combunox
55. Oxycodone Hydrochloride Component Of Percocet
56. Oxycodone Hydrochloride Component Of Percodan
57. Oxycodone Hydrochloride Component Of Roxiprin
58. Oxycodone Hydrochloride Component Of Targiniq
59. Oxycodone Hydrochloride Component Of Xartemis
60. Percodan-demi Component Oxycodone Hydrochloride
61. Q27107601
62. Oxycodone Hydrochloride Component Of Percodan-demi
63. 14-hydroxy-3-methoxy-17-methyl-4,5alpha-epoxymorphinan-6-one Hydrochloride
64. Oxycodone Hydrochloride, European Pharmacopoeia (ep) Reference Standard
65. Oxycodone Hydrochloride, United States Pharmacopeia (usp) Reference Standard
66. (5?)-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride
67. (5alpha,17s)-14-hydroxy-3-methoxy-17-methyl-6-oxo-4,5-epoxymorphinan-17-ium Chloride
68. 4,5.alpha.-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride
69. Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, Hydrochloride, (5.alpha.)-
70. Oxycodone Hydrochloride Solution, 1.0 Mg/ml In Methanol, Analytical Standard, For Drug Analysis
Molecular Weight | 351.8 g/mol |
---|---|
Molecular Formula | C18H22ClNO4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 1 |
Exact Mass | 351.1237359 g/mol |
Monoisotopic Mass | 351.1237359 g/mol |
Topological Polar Surface Area | 59 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 553 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Oxecta |
Drug Label | OXECTA (oxycodone HCl, USP) tablets are an immediate-release opioid analgesic intended for oral administration only. OXECTA contains oxycodone HCl, USP as the active analgesic ingredient. The tablets are round, convex, white and debossed with the str... |
Active Ingredient | Oxycodone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 7.5mg; 5mg |
Market Status | Prescription |
Company | Acura Pharms |
2 of 4 | |
---|---|
Drug Name | Oxycodone hydrochloride |
Drug Label | DESCRIPTIONOxyContin (oxycodone hydrochloride controlled-release) Tablets are an opioid analgesic supplied in 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg, and 160 mg tablet strengths for oral administration... |
Active Ingredient | Oxycodone hydrochloride |
Dosage Form | Tablet, extended release; Tablet; Capsule; Solution |
Route | oral; Oral |
Strength | 30mg; 100mg/5ml; 15mg; 5mg; 10mg; 5mg/5ml; 80mg; 40mg; 20mg |
Market Status | Tentative Approval; Prescription |
Company | Corepharma; Vintage Pharms; Amneal Pharms; Impax Pharms; Aurolife Pharma; Avanthi; Teva; Endo Pharms; Sun Pharm Inds; Coastal Pharms; Rhodes Pharms; Mallinckrodt; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Lehigh Valley; Alvog |
3 of 4 | |
---|---|
Drug Name | Oxecta |
Drug Label | OXECTA (oxycodone HCl, USP) tablets are an immediate-release opioid analgesic intended for oral administration only. OXECTA contains oxycodone HCl, USP as the active analgesic ingredient. The tablets are round, convex, white and debossed with the str... |
Active Ingredient | Oxycodone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 7.5mg; 5mg |
Market Status | Prescription |
Company | Acura Pharms |
4 of 4 | |
---|---|
Drug Name | Oxycodone hydrochloride |
Drug Label | DESCRIPTIONOxyContin (oxycodone hydrochloride controlled-release) Tablets are an opioid analgesic supplied in 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg, and 160 mg tablet strengths for oral administration... |
Active Ingredient | Oxycodone hydrochloride |
Dosage Form | Tablet, extended release; Tablet; Capsule; Solution |
Route | oral; Oral |
Strength | 30mg; 100mg/5ml; 15mg; 5mg; 10mg; 5mg/5ml; 80mg; 40mg; 20mg |
Market Status | Tentative Approval; Prescription |
Company | Corepharma; Vintage Pharms; Amneal Pharms; Impax Pharms; Aurolife Pharma; Avanthi; Teva; Endo Pharms; Sun Pharm Inds; Coastal Pharms; Rhodes Pharms; Mallinckrodt; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Lehigh Valley; Alvog |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
33
PharmaCompass offers a list of Oxycodone Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxycodone Hydrochloride manufacturer or Oxycodone Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxycodone Hydrochloride manufacturer or Oxycodone Hydrochloride supplier.
PharmaCompass also assists you with knowing the Oxycodone Hydrochloride API Price utilized in the formulation of products. Oxycodone Hydrochloride API Price is not always fixed or binding as the Oxycodone Hydrochloride Price is obtained through a variety of data sources. The Oxycodone Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oxygesic manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxygesic, including repackagers and relabelers. The FDA regulates Oxygesic manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxygesic API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxygesic manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxygesic supplier is an individual or a company that provides Oxygesic active pharmaceutical ingredient (API) or Oxygesic finished formulations upon request. The Oxygesic suppliers may include Oxygesic API manufacturers, exporters, distributors and traders.
click here to find a list of Oxygesic suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Oxygesic DMF (Drug Master File) is a document detailing the whole manufacturing process of Oxygesic active pharmaceutical ingredient (API) in detail. Different forms of Oxygesic DMFs exist exist since differing nations have different regulations, such as Oxygesic USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Oxygesic DMF submitted to regulatory agencies in the US is known as a USDMF. Oxygesic USDMF includes data on Oxygesic's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oxygesic USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Oxygesic suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Oxygesic Drug Master File in Japan (Oxygesic JDMF) empowers Oxygesic API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Oxygesic JDMF during the approval evaluation for pharmaceutical products. At the time of Oxygesic JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Oxygesic suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Oxygesic Drug Master File in Korea (Oxygesic KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Oxygesic. The MFDS reviews the Oxygesic KDMF as part of the drug registration process and uses the information provided in the Oxygesic KDMF to evaluate the safety and efficacy of the drug.
After submitting a Oxygesic KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Oxygesic API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Oxygesic suppliers with KDMF on PharmaCompass.
A Oxygesic CEP of the European Pharmacopoeia monograph is often referred to as a Oxygesic Certificate of Suitability (COS). The purpose of a Oxygesic CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Oxygesic EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Oxygesic to their clients by showing that a Oxygesic CEP has been issued for it. The manufacturer submits a Oxygesic CEP (COS) as part of the market authorization procedure, and it takes on the role of a Oxygesic CEP holder for the record. Additionally, the data presented in the Oxygesic CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Oxygesic DMF.
A Oxygesic CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Oxygesic CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Oxygesic suppliers with CEP (COS) on PharmaCompass.
A Oxygesic written confirmation (Oxygesic WC) is an official document issued by a regulatory agency to a Oxygesic manufacturer, verifying that the manufacturing facility of a Oxygesic active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Oxygesic APIs or Oxygesic finished pharmaceutical products to another nation, regulatory agencies frequently require a Oxygesic WC (written confirmation) as part of the regulatory process.
click here to find a list of Oxygesic suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oxygesic as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Oxygesic API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Oxygesic as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Oxygesic and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oxygesic NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Oxygesic suppliers with NDC on PharmaCompass.
Oxygesic Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxygesic GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxygesic GMP manufacturer or Oxygesic GMP API supplier for your needs.
A Oxygesic CoA (Certificate of Analysis) is a formal document that attests to Oxygesic's compliance with Oxygesic specifications and serves as a tool for batch-level quality control.
Oxygesic CoA mostly includes findings from lab analyses of a specific batch. For each Oxygesic CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxygesic may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxygesic EP), Oxygesic JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxygesic USP).